拥有20年的手术经验,用于原生和假设的中枢内心炎
Antonella Galeone1, Jacopo Gardellini1, Venanzio Di Nicola1
1Department of Surgery, Dentistry, Pediatrics and Gynecology, Division of Cardiac Surgery, University of Verona, 37126 Verona, Italy.
Medicina (Kaunas, Lithuania)
|June 28, 2023
概括
对心肌内脏炎的手术具有重大风险. 60岁以上的患者年龄是一个关键的死亡风险因素,而心心门修复提供了保护. 对于原生膜内心炎,再干预率较低.
科学领域:
- 心血管外科心血管外科
- 传染性内心炎感染性内心炎
- 门置换手术 手术 门置换手术
背景情况:
- 感染性内心炎影响心交 (本源或假体) 提出了重大的外科挑战.
- 评估手术结果对心肌内心炎对于患者管理至关重要.
- 手术干预的早期和长期结果需要彻底评估.
研究的目的:
- 评估隔离的额头肌原生和假体膜传染性内心炎的手术治疗的早期和长期结果.
- 确定影响这些患者死亡率和再干预率的风险因素.
主要方法:
- 在2001年至2021年期间,对130名因传染性内心炎而接受了中心手术的患者进行了回顾性审查.
- 分析包括术前/术后特征,死亡率和重新干预率.
- 与原生膜内心炎和假膜内心炎之间的比较,以及对膜修复和更换之间的比较.
主要成果:
- 总死亡率为39%,平均存活时间为11.8年. 60岁以上的患者的生存率明显降低 (p < 0.001).
- 中枢的修复显示出更好的生存率 (p=0.06) 的趋势,并被确定为保护因素.
- 机械假肢提供了比生物假肢更好的生存率 (p < 0.001). 原生膜内心炎的重复干预自由度较高 (p=0.04).
结论:
- 额头膜内心炎的手术治疗与严重的发病率和死亡率有关.
- 患者年龄>60岁是死亡率的独立风险因素.
- 在适合感染性内心炎患者的情况下,建议在可行的情况下进行中枢修复.
相关概念视频
Endocarditis III: Medical Management
8
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8
Mitral Stenosis III: Medical Management
14
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Mitral Valve Prolapse II: Assessment and Management
23
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
23
Mitral Stenosis I: Introduction
18
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
18
Endocarditis I: Introduction
13
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
13
Mitral Regurgitation III: Medical Management
20
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
20


